FAM72A expression based on
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Comparison | Statistical significance |
Normal-vs-Primary | 1.514440E-01 |
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.429000E-01 |
Normal-vs-Stage2 |
1.456230E-02 |
Normal-vs-Stage3 |
1.138630E-01 |
Normal-vs-Stage4 |
3.108400E-01 |
Stage1-vs-Stage2 |
8.002000E-04 |
Stage1-vs-Stage3 |
2.859400E-01 |
Stage1-vs-Stage4 |
9.062800E-01 |
Stage2-vs-Stage3 |
5.002100E-02 |
Stage2-vs-Stage4 |
1.456370E-02 |
Stage3-vs-Stage4 |
3.711400E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.387800E-01 |
Normal-vs-AfricanAmerican |
1.877560E-01 |
Normal-vs-Asian |
8.864000E-02 |
Caucasian-vs-AfricanAmerican |
6.198200E-01 |
Caucasian-vs-Asian |
1.994970E-01 |
AfricanAmerican-vs-Asian |
6.568200E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.096040E-01 |
Normal-vs-Female |
1.783800E-01 |
Male-vs-Female |
4.589600E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.781400E-01 |
Normal-vs-Age(41-60Yrs) |
4.392200E-02 |
Normal-vs-Age(61-80Yrs) |
1.253970E-01 |
Normal-vs-Age(81-100Yrs) |
8.280400E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.695100E-03 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.059400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.508600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.805200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.476370E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.292590E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Classical-VS-Tall |
3.683000E-01 |
Classical-VS-Follicular |
5.142200E-03 |
Classical-VS-Other |
4.539800E-01 |
Classical-VS-Normal |
2.514200E-01 |
Tall-VS-Follicular |
3.297500E-02 |
Tall-VS-Other |
1.411800E-01 |
Tall-VS-Normal |
6.732600E-01 |
Follicular-VS-Other |
7.307200E-01 |
Follicular-VS-Normal |
2.621600E-02 |
Other-VS-Normal |
8.508500E-02 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.112400E-02 |
Normal-vs-N1 |
2.144600E-01 |
N0-vs-N1 |
1.639580E-01 |
|
|